Le code SH/NC 3002 est hors champ d'application pour la préparation RDUE.
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products Le moteur de champ d'application indexé renvoie Out of scope pour ce code. No Annex I scope match was found for this indexed CN code.
Pourquoi cette page de référence donne cette réponse.
- Description du code
- Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products
- Base annexe I
- Aucune entrée directe à l'annexe I
- Base de la source
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Lignes parentes, filles et voisines.
La vue bibliothèque sert à la navigation de référence. Utilisez le vérificateur lorsque vous voulez lancer un autre code comme action.
30produits pharmaceutiquesout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout300211malaria diagnostic test kitsout300212antisera and other blood fractionsout300213immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleout300214immunological products, mixed, not put up in measured doses or in forms or packings for retail saleout300215immunological products, put up in measured doses or in forms or packings for retail saleout300219immunological products, n.e.s. (code possibly empty, preceding subheadings seem exhaustive)out300220vaccines for human medicineout300230vaccines for veterinary medicineout300231foot-and-mouth vaccinesout3001dried glands and other organs for organo-therapeutic uses, whether or not powdered; extracts of glands or other organs or their secretions, for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, n.e.s.out3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out3004medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)out3005wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposesout3006pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90out
Ce que cela signifie pour la préparation.
Cette ligne ne déclenche pas directement de collecte de preuves dans le résultat de champ d'application actuel.
Regulation (EU) 2023/1115 Annex I — relevant productsconsulté le 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115consulté le 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)consulté le 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)consulté le 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8consulté le 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingconsulté le 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersconsulté le 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)consulté le 2026-08-08